AU8105798A - Mammalian cell transduction for use in gene therapy - Google Patents
Mammalian cell transduction for use in gene therapyInfo
- Publication number
- AU8105798A AU8105798A AU81057/98A AU8105798A AU8105798A AU 8105798 A AU8105798 A AU 8105798A AU 81057/98 A AU81057/98 A AU 81057/98A AU 8105798 A AU8105798 A AU 8105798A AU 8105798 A AU8105798 A AU 8105798A
- Authority
- AU
- Australia
- Prior art keywords
- gene therapy
- mammalian cell
- cell transduction
- transduction
- mammalian
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000001415 gene therapy Methods 0.000 title 1
- 210000004962 mammalian cell Anatomy 0.000 title 1
- 230000026683 transduction Effects 0.000 title 1
- 238000010361 transduction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0669—Bone marrow stromal cells; Whole bone marrow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97201480 | 1997-05-16 | ||
EP97201480 | 1997-05-16 | ||
EP98200382 | 1998-02-09 | ||
EP98200382A EP0938904A1 (en) | 1998-02-09 | 1998-02-09 | Mammalian cell transduction for use in gene therapy |
PCT/EP1998/003013 WO1998053063A2 (en) | 1997-05-16 | 1998-05-18 | Mammalian cell transduction for use in gene therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
AU8105798A true AU8105798A (en) | 1998-12-11 |
Family
ID=26146488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU81057/98A Abandoned AU8105798A (en) | 1997-05-16 | 1998-05-18 | Mammalian cell transduction for use in gene therapy |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0980264A2 (en) |
AU (1) | AU8105798A (en) |
CA (1) | CA2289918A1 (en) |
WO (1) | WO1998053063A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000017375A2 (en) * | 1998-09-23 | 2000-03-30 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
AU1685201A (en) * | 1999-12-01 | 2001-06-12 | Centre For Translational Research In Cancer | Drug inducible system and use thereof |
GB0325379D0 (en) * | 2003-10-30 | 2003-12-03 | Oxford Biomedica Ltd | Vectors |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69232438T2 (en) * | 1991-08-07 | 2002-10-10 | W. French Anderson | INTERNAL RIBOSOM INPUTS INCLUDING RETROVIRAL VECTORS |
WO1996009400A1 (en) * | 1994-09-19 | 1996-03-28 | Systemix, Inc. | Methods for genetically modifying hematopoietic stem cells |
US5681746A (en) * | 1994-12-30 | 1997-10-28 | Chiron Viagene, Inc. | Retroviral delivery of full length factor VIII |
DE69612660T2 (en) * | 1995-03-29 | 2002-04-18 | Austrian Nordic Biotherapeutics Ag, Wien | PSEUDOTYPIZED RETROVIRAL VECTORS |
JPH11507244A (en) * | 1995-10-05 | 1999-06-29 | カイロン コーポレイション | Retroviral vector pseudotyped with SRV-3 envelope glycoprotein sequence |
US5766945A (en) * | 1996-02-13 | 1998-06-16 | Fred Hutchinson Cancer Research Center | 10A1 Retroviral packaging cells and uses thereof |
-
1998
- 1998-05-18 WO PCT/EP1998/003013 patent/WO1998053063A2/en not_active Application Discontinuation
- 1998-05-18 EP EP98930718A patent/EP0980264A2/en not_active Withdrawn
- 1998-05-18 CA CA002289918A patent/CA2289918A1/en not_active Abandoned
- 1998-05-18 AU AU81057/98A patent/AU8105798A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0980264A2 (en) | 2000-02-23 |
WO1998053063A3 (en) | 1999-03-18 |
WO1998053063A2 (en) | 1998-11-26 |
CA2289918A1 (en) | 1998-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU5998598A (en) | Electrochemical cell | |
AUPO585797A0 (en) | Improved electrochemical cell | |
AU2023995A (en) | Electrochemical cell | |
AU6909198A (en) | Leaf-specific gene expression in transgenetic plants | |
AU7595498A (en) | Medicament dispensing cell | |
AU1201600A (en) | Controlling gene expression in living cells | |
HUP0104681A3 (en) | Human hybrid host cell for mammalian gene expression | |
AU9248398A (en) | Compounds and methods for regulating cell adhesion | |
AU3919997A (en) | Nucleic acid constructs containing hybrid promoters for use in gene therapy | |
AU6229498A (en) | Composition for gene introduction into cell | |
AU4378996A (en) | Cell compositions for use in transplantation and ex vivo gene therapy | |
AU7476198A (en) | Cell proliferation related genes | |
AU1226699A (en) | Composite suitable for use in electrochemical cells | |
AU1618500A (en) | Human cell surface receptor proteins | |
AU1531695A (en) | Electro-chemical cell | |
AU6468398A (en) | Methods for producing polypeptides in respiratory-deficient cells | |
AU8105798A (en) | Mammalian cell transduction for use in gene therapy | |
GB2314332B (en) | Gene expression in mammalian cells | |
GB9714936D0 (en) | Cell culture products | |
AU1912999A (en) | Electrochemical cell balance | |
AU6634298A (en) | Biosensor for cells | |
AU6736598A (en) | Methods for selecting cells and their uses | |
AU9380898A (en) | Mammalian circadian rhythm-like gene | |
AU2104497A (en) | Cell stimulation | |
AU7362398A (en) | B cell receptor associated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |